Efficacy of a new vacuum erection device (Vigor 2020) for erectile dysfunction: A retrospective study in Japan
International Journal of Urology · 2024
DOI: 10.1111/iju.15574 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift International Journal of Urology, 2024. Verfasst von Masato Shirai und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Juntendo University Urayasu Hospital, Chiba, Japan. Hauptthemen laut MEDLINE: Erectile Dysfunction, Penile Erection. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
Objectives
The vacuum erection device (VED) is a second‐line treatment tool recommended in erectile dysfunction (ED) guidelines but has long been unavailable in Japan. A new VED, Vigor 2020 ® (A & HB Company Limited, Tokyo, Japan), has now been manufactured and received medical approval from the Pharmaceuticals and Medical Devices Agency in Japan. We conducted a retrospective observational study of ED patients who used Vigor 2020 in clinical practice.
Methods
We analyzed male ED patients aged ≥20 years treated with Vigor 2020 in our outpatient clinics. The primary endpoint was improvement of erection as evaluated by an Erection Hardness Score (EHS) of ≥1 point. Secondary endpoints were improvement of sexual function and adverse events as evaluated by the International Index of Erectile Function (IIEF) and Male Sexual Health Questionnaire for assessing ejaculatory dysfunction (MSHQ‐EjD).
Results
Thirty‐three patients (mean age, 57.21 [27–86] years) could be evaluated before and after using Vigor 2020. Among the 16 patients with baseline EHS ≤2, 14 (93.33%) improved by ≥1 point, and 10 of these 16 patients (62.50%) improved to EHS ≥3 and could insert vaginally. Significant improvement was observed for IIEF total score and for the MSHQ‐EjD in patients with an EHS of ≥3 after use of Vigor 2020. No patient experienced significant adverse events.
Conclusions
The Vigor 2020 may be an efficacious treatment tool for ED. Patients with significant ED experienced not only significant improvement of erection but also improvement of ejaculation with its use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Juntendo University Urayasu Hospital, Chiba, Japan.
- Department of Urology, Osaka University School of Medicine, Osaka, Japan.
- Iwasa Clinic, Osaka, Japan.
- D Clinic Tokyo, Tokyo, Japan.
- East Ekimae Clinic, Tokyo, Japan.
ORCID-Profile: Masato Shirai, Keisuke Ishikawa, Shinichiro Fukuhara, Akira Tsujimura
Zitieren
APA
Shirai, M., Sano, M., Anno, Y., Ishikawa, K., Taniguchi, A., Kure, A., Uesaka, Y., Nozaki, T., Fukuhara, S., Iwasa, A., Kobayashi, K., Kato, J., & Tsujimura, A. (2024). Efficacy of a new vacuum erection device (Vigor 2020) for erectile dysfunction: A retrospective study in Japan. International Journal of Urology. https://doi.org/10.1111/iju.15574
Vancouver
Shirai M, Sano M, Anno Y, Ishikawa K, Taniguchi A, Kure A, et al. Efficacy of a new vacuum erection device (Vigor 2020) for erectile dysfunction: A retrospective study in Japan. International Journal of Urology. 2024. doi:10.1111/iju.15574
BibTeX
@article{Shirai2024,
author = {Shirai, Masato and Sano, Masataka and Anno, Yuta and Ishikawa, Keisuke and Taniguchi, Ayumu and Kure, Akimasa and Uesaka, Yuka and Nozaki, Taiji and Fukuhara, Shinichiro and Iwasa, Atsushi and Kobayashi, Kazuhiro and Kato, Jun and Tsujimura, Akira},
title = {Efficacy of a new vacuum erection device (Vigor 2020) for erectile dysfunction: A retrospective study in Japan},
journal = {International Journal of Urology},
year = {2024},
doi = {10.1111/iju.15574}
}
EUVIMED